Literature DB >> 19183073

Jupiter to Earth: CRP promotes atherothrombosis.

I Jialal, S Devaraj.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19183073      PMCID： PMC2662775          DOI： 10.1089/met.2009.EDI

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN： 1540-4196            Impact factor:   1.894


× No keyword cloud information.
  14 in total

1.  Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects.

Authors:  Radjesh J Bisoendial; John J P Kastelein; Stephan L M Peters; Johannes H M Levels; Rakesh Birjmohun; Joris I Rotmans; Daniel Hartman; Joost C M Meijers; Marcel Levi; Erik S G Stroes
Journal:  J Lipid Res       Date:  2007-01-26       Impact factor: 5.922

2.  Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.

Authors:  I Jialal; D Stein; D Balis; S M Grundy; B Adams-Huet; S Devaraj
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

3.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Authors:  John A Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

4.  High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Authors:  Terje R Pedersen; Ole Faergeman; John J P Kastelein; Anders G Olsson; Matti J Tikkanen; Ingar Holme; Mogens Lytken Larsen; Fredrik S Bendiksen; Christina Lindahl; Michael Szarek; John Tsai
Journal:  JAMA       Date:  2005-11-16       Impact factor: 56.272

Review 5.  C-reactive protein comes of age.

Authors:  Subodh Verma; Paul E Szmitko; Paul M Ridker
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2005-01

6.  The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells.

Authors:  Mohan R Dasu; Sridevi Devaraj; Terry W Du Clos; Ishwarlal Jialal
Journal:  J Lipid Res       Date:  2006-12-09       Impact factor: 5.922

7.  Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.

Authors:  James A de Lemos; Michael A Blazing; Stephen D Wiviott; Eldrin F Lewis; Keith A A Fox; Harvey D White; Jean-Lucien Rouleau; Terje R Pedersen; Laura H Gardner; Robin Mukherjee; Karen E Ramsey; Joanne Palmisano; David W Bilheimer; Marc A Pfeffer; Robert M Califf; Eugene Braunwald
Journal:  JAMA       Date:  2004-08-30       Impact factor: 56.272

8.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

Authors:  Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn
Journal:  N Engl J Med       Date:  2008-11-09       Impact factor: 91.245

9.  Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance.

Authors:  Ishwarlal Jialal; Subodh Verma; Sridevi Devaraj
Journal:  Clin Chem       Date:  2008-12-18       Impact factor: 8.327

10.  Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors.

Authors:  L Bowman; J Armitage; R Bulbulia; S Parish; R Collins
Journal:  Am Heart J       Date:  2007-09-06       Impact factor: 4.749
View more
  2 in total

Review 1.  Inflammation, atherosclerosis, and psoriasis.

Authors:  David Siegel; Sridevi Devaraj; Anupam Mitra; Siba P Raychaudhuri; Smriti K Raychaudhuri; Ishwarlal Jialal
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

2.  Human C-reactive protein does not promote atherosclerosis in transgenic rabbits.

Authors:  Tomonari Koike; Shuji Kitajima; Ying Yu; Kazutoshi Nishijima; Jifeng Zhang; Yukio Ozaki; Masatoshi Morimoto; Teruo Watanabe; Sucharit Bhakdi; Yujiro Asada; Y Eugene Chen; Jianglin Fan
Journal:  Circulation       Date:  2009-11-09       Impact factor: 29.690
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.